Dann L Parker

Title: The Innovations of Dann L Parker

Introduction

Dann L Parker is a notable inventor based in Cranford, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues. His work has the potential to impact the treatment of various cardiovascular conditions.

Latest Patents

Parker holds a patent for Factor IXa inhibitors. This invention provides a compound of Formula I, along with pharmaceutical compositions that include one or more of these compounds. The methods outlined in the patent are aimed at treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build-up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds developed are selective Factor IXa inhibitors, showcasing Parker's innovative approach to addressing serious medical conditions.

Career Highlights

Throughout his career, Dann L Parker has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Mochida Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Parker has collaborated with notable colleagues, including Ting Zhang and Yi-Heng Chen. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical field.

Conclusion

Dann L Parker's contributions to the field of pharmaceuticals through his patent for Factor IXa inhibitors highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.